leadf
logo-loader
viewEmyria Ltd

Emerald Clinics gears up for an IPO

Emerald Clinics Ltd chief executive officer and managing director Dr Michael Winlo updates Proactive on the healthcare technology and services company’s science-driven and data-underpinned approach in the complex world of care.

The CEO spoke about what drives the company, how it creates wealth and about its business model as Emerald Clinics gears up for an IPO.

Quick facts: Emyria Ltd

Price: 0.079 AUD

ASX:EMD
Market: ASX
Market Cap: $16.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Emyria Ltd named herein, including the promotion by the Company of Emyria Ltd in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Emyria's Michael Winlo details new global partnership with UK-based Sapphire...

Emyria Ltd’s (ASX:EMD) Dr Michael Winlo caught up with Proactive's Andrew Scott after reporting that its clinical operations subsidiary, Emerald Clinics, has entered into a global partnership with UK-based Sapphire Medical Clinics. The partnership will provide a new source of data to bolster...

1 day, 18 hours ago

2 min read